is the compounded semaglutide safe safe? Benefits and risks GLP-1 Semaglutide Rx | FancyMeds
Description
Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist, not a GLP-1 receptor agonist
The most common side effects are gastrointestinal such as nausea, and changes to digestion particularly when starting or increasing your dose
do not inject at least one week prior to your surgery or procedure
Byetta product information
Its a carefully formulated approach to a complex problem
A 2025 head-to-head SURMOUNT-5 trial , also in NEJM , directly compared tirzepatide to semaglutide and confirmed tirzepatides superior weight loss outcomes
